Accordingly, identical knock-in models of adult MLL-AF9 and MLL-ENL leukaemia have shown that disease originates more efficiently from different HSPC populations when comparing both fusions, and that MLL-AF9 expression in LT-HSC causes a more aggressive leukaemia as compared to disease derived from GMP [157,159]. This evidence concerns the gene MLLT3 and leukemia.